RNR

RNR

USD

RenaissanceRe Holdings Ltd. Common Stock

$243.240+4.320 (1.808%)

实时价格

金融服务
Insurance - Reinsurance
百慕大

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$238.920

最高价

$243.890

最低价

$238.700

成交量

0.05M

公司基本面

市值

11.8B

所属行业

Insurance - Reinsurance

国家/地区

Bermuda

交易统计

平均成交量

0.52M

交易所

NYQ

货币

USD

52周价格范围

最低价 $208.98当前价 $243.240最高价 $300

AI分析报告

最后更新: 2025年5月1日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

RNR: RenaissanceRe Holdings Ltd. Common Stock - What's Happening and What to Watch

Stock Symbol: RNR Generate Date: 2025-05-01 23:35:31

Alright, let's break down what's been going on with RenaissanceRe, ticker RNR, and see what the recent activity might suggest. We'll look at the latest news, check out how the stock price has been moving, and see what some automated predictions are saying.

Recent News Buzz: A Mixed Bag with Some Positive Signals

Looking at the news from the past few weeks, it's a bit of a mixed picture for RNR, but there are some definite points of interest.

First off, we saw a couple of investment firms, Keefe, Bruyette & Woods and Morgan Stanley, come out with positive takes in late April. Keefe, Bruyette & Woods kept their "Outperform" rating and even nudged their price target up slightly to $282. More notably, Morgan Stanley actually upgraded the stock from "Equal-Weight" to "Overweight" and gave a pretty significant bump to their price target, raising it from $235 all the way to $275. That kind of upgrade from a major firm often catches people's attention.

On the flip side, not everyone is quite so bullish. JMP Securities reiterated their "Market Perform" rating, which is essentially a neutral stance – they're not saying buy or sell right now. Earlier in April, both Barclays and Wells Fargo maintained their ratings ("Underweight" and "Overweight," respectively) but lowered their price targets slightly. Barclays dropped theirs to $231, and Wells Fargo trimmed theirs to $271.

Then there's the company's own performance update. RenaissanceRe reported its first-quarter results for 2025. They had $161.1 million in net income available to common shareholders, which sounds good. However, they also reported an operating loss of $69.8 million attributable to common shareholders. That operating loss is something investors will look at closely. On a more positive note from the report, the company saw growth in its book value per share (0.2%) and tangible book value per share plus dividends (0.9%). Plus, they bought back about 1.5 million shares, which can sometimes signal management's confidence in the company's value.

So, what's the overall vibe from the news? It's definitely not a unanimous cheerleading section. You have some analysts getting more positive recently, particularly Morgan Stanley with that upgrade and big target raise. But you also have others maintaining a neutral or cautious stance, and the Q1 results had that operating loss mixed in with the net income and book value growth. The most recent analyst action (late April) seems to lean a bit more positive than the earlier April actions.

Price Check: A Recent Rollercoaster Ride

Now, let's look at what the stock price itself has been doing over the last few months. If you look at the chart since early February, RNR had a pretty decent run-up, climbing from the low $230s into the $240s and even touching the $250 mark briefly in early April.

But then came a sharp drop around April 4th, taking the price down significantly into the low $220s. That was a noticeable dip! Since that drop, the stock has bounced back somewhat and has been trading in a range, mostly between the low $230s and low $240s.

The price on May 1st closed around $237.20. This puts it firmly within that post-dip trading range.

What about the AI's take on the very near future? The prediction model suggests today (May 1st) would see basically no change (0.00%), which lines up pretty well with the actual close being close to the open. For the next day, it predicts a slight increase of 1.14%. The day after that, it sees a small dip of 0.46%. So, the AI is forecasting minor fluctuations right around the current levels, with a small positive nudge expected tomorrow.

Putting It Together: What Might This Suggest?

Based on the news, the recent price action, and the AI's short-term view, what's the potential outlook?

The news is mixed, but the recent analyst upgrades and target raises, especially from Morgan Stanley, add a positive layer that wasn't there earlier in April. The Q1 results had some good points (net income, book value growth, buybacks) alongside the operating loss.

The price chart shows the stock has recovered some ground after a sharp fall and seems to be consolidating in a range. The AI isn't predicting any huge moves immediately, just small ups and downs, with a slight positive bias for tomorrow.

Putting it all together, the situation seems to lean towards a cautious hold or perhaps a potential for slight upward movement if the recent positive analyst sentiment gains traction and outweighs concerns about the operating loss or the earlier target cuts. It doesn't look like a clear-cut "buy everything now" or "sell everything immediately" situation based on this data alone.

If someone were considering getting into RNR based on the more positive analyst views and the stock holding above its recent lows, a potential entry consideration might be around the current price level (around $237-$238) or perhaps on any slight dip within the recent trading range. This aligns somewhat with the entry points suggested by the recommendation data ($239.85 - $241.16), suggesting that level is seen as a reasonable area if the price moves up slightly.

For managing risk, the recommendation data suggests a potential stop-loss level around $217.63. This is below the low point of that sharp dip in early April, which makes sense as a level where you might decide the recent recovery isn't holding. On the upside, a potential take-profit level suggested is $256.67. This is well above the recent trading range and would represent a significant move higher, perhaps aligning with some of the higher analyst price targets if the stock gets there. Remember, these are just potential levels based on the data provided, not guarantees.

Company Context: Reinsurance Matters

It's helpful to remember that RenaissanceRe is primarily a reinsurance company. This means they essentially insure other insurance companies, particularly against big, costly events like natural disasters (hurricanes, earthquakes) and other major risks. Their performance is heavily influenced by these events and the pricing environment for reinsurance. The Q1 results and analyst views are likely tied to how they performed in this specific, sometimes volatile, business environment. The company description also mentions they deal with various specialty lines, which adds another layer to their business.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

相关新闻

Analyst Upgrades

Keefe, Bruyette & Woods Maintains Outperform on RenaissanceRe Holdings, Raises Price Target to $282

Keefe, Bruyette & Woods analyst Meyer Shields maintains RenaissanceRe Holdings with a Outperform and raises the price target from $279 to $282.

查看更多
Keefe, Bruyette & Woods Maintains Outperform on RenaissanceRe Holdings, Raises Price Target to $282
Analyst Upgrades

Morgan Stanley Upgrades RenaissanceRe Holdings to Overweight, Raises Price Target to $275

Morgan Stanley analyst Michael Phillips upgrades RenaissanceRe Holdings from Equal-Weight to Overweight and raises the price target from $235 to $275.

查看更多
Morgan Stanley Upgrades RenaissanceRe Holdings to Overweight, Raises Price Target to $275
Analyst Upgrades

JMP Securities Reiterates Market Perform on RenaissanceRe Holdingsto Market Perform

JMP Securities analyst Karol Chmiel reiterates RenaissanceRe Holdings from Market Perform to Market Perform.

查看更多
JMP Securities Reiterates Market Perform on RenaissanceRe Holdingsto Market Perform
BusinessWire

RenaissanceRe Reports $161.1 Million of Net Income Available to Common Shareholders and $69.8 million of Operating Loss Attributable to Common Shareholders in Q1 2025.

Growth in book value per share of 0.2% and growth in tangible book value per share plus change in accumulated dividends of 0.9%, in Q1 2025. Repurchased approximately 1.5 million common shares at an aggregate cost of

查看更多
RenaissanceRe Reports $161.1 Million of Net Income Available to Common Shareholders and $69.8 million of Operating Loss Attributable to Common Shareholders in Q1 2025.
Analyst Upgrades

Barclays Maintains Underweight on RenaissanceRe Holdings, Lowers Price Target to $231

Barclays analyst Alex Scott maintains RenaissanceRe Holdings with a Underweight and lowers the price target from $234 to $231.

查看更多
Barclays Maintains Underweight on RenaissanceRe Holdings, Lowers Price Target to $231
Analyst Upgrades

Wells Fargo Maintains Overweight on RenaissanceRe Holdings, Lowers Price Target to $271

Wells Fargo analyst Elyse Greenspan maintains RenaissanceRe Holdings with a Overweight and lowers the price target from $277 to $271.

AI预测Beta

AI建议

看涨

更新于: 2025年5月3日 21:36

看跌中性看涨

61.8% 置信度

风险与交易

风险等级1/5
低风险
适合于
价值增长保守
交易指南

入场点

$242.38

止盈点

$248.14

止损点

$218.94

关键因素

PDI 4.6高于MDI 3.0,且ADX 27.9,表明看涨趋势
当前价格非常接近支撑水平$242.98,表明有强烈的买入机会
交易量是平均值的5.6倍(5,333),表明极强的买入压力
MACD 0.3344低于信号线0.3442,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。